Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "translational"

170 News Found

Strand Life launches advanced proteomics capabilities
Biopharma | May 19, 2026

Strand Life launches advanced proteomics capabilities

The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample


Industry-academia partnership expands access to advanced life sciences analytics for Indian researchers
News | May 13, 2026

Industry-academia partnership expands access to advanced life sciences analytics for Indian researchers

High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration


FUJIFILM Biosciences & NextCell launch platform to standardize regenerative medicine development
R&D | May 11, 2026

FUJIFILM Biosciences & NextCell launch platform to standardize regenerative medicine development

The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows


Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push
News | May 08, 2026

Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push

The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities


Illumina showcases multi-omics potential to advance precision medicine in India
Biopharma | May 08, 2026

Illumina showcases multi-omics potential to advance precision medicine in India

The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru


Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics
interviews | April 29, 2026

Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics

Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies


The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings
interviews | April 28, 2026

The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings

With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints


Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D
People | April 27, 2026

Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D

His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research


Vision 360 brings academia, industry together to advance ophthalmic therapies
Healthcare | April 25, 2026

Vision 360 brings academia, industry together to advance ophthalmic therapies

VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care


Experts convene in India to push for urgent action on dengue treatment gaps
Public Health | April 23, 2026

Experts convene in India to push for urgent action on dengue treatment gaps

Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches